This week’s health news is marked by significant collaborative efforts and legal victories. Antares Therapeutics has secured a $1.9 billion potential deal with Novartis to develop cancer therapies aimed at challenging targets. Meanwhile, Bayer celebrated a major legal win as the U.S. Supreme Court substantially reduced lawsuits related to its Roundup weedkiller.<\/p>\n
Ebola continues to pose a formidable threat, with the Africa CDC estimating $1.4 billion in funding needs, tripling initial estimates. Concurrently, the U.S. is bolstering its FDA workforce and tackling influenza outbreaks, marking a crucial time for public health strategy.<\/p>\n
In the business health sector, H.B. Fuller has agreed to acquire the UK’s Advanced Medical Solutions Group for $942 million, and Dutch company Prosus has invested $460 million in the French health tech firm Alan, valuing it at $6.3 billion and highlighting the robust activity in health-oriented investments.<\/p>\n
(With inputs from agencies.)<\/p>\n","protected":false},"excerpt":{"rendered":"This week’s health news is marked by significant collaborative efforts and legal victories. Antares Therapeutics has secured a…\n","protected":false},"author":2,"featured_media":92436,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[127],"tags":[39810,2112,2059,37410,1750,1002,250,206,45357,9053,46374],"class_list":["post-92435","post","type-post","status-publish","format-standard","has-post-thumbnail","category-novartis","tag-bayer","tag-cancer","tag-collaboration","tag-ebola","tag-funding","tag-health","tag-investment","tag-novartis","tag-roundup","tag-therapy","tag-us-supreme-court"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116814588406573629","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/92435","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=92435"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/92435\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/92436"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=92435"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=92435"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=92435"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}